Mettu PS, Allingham MJ, Cousins SW (2021) Phase 1 clinical trial of elamipretide in dry age-related macular degeneration and noncentral geographic atrophy: ReCLAIM NCGA study
Drawing on sports nutrition science and customer feedback, the team created formulations that deliver effective doses in convenient formats
Dihexa demonstrates unusually high oral bioavailability for a peptide compound, estimated at 40-60% in animal models compared to the typical 5% or less for most peptides
Injectable may offer complementary systemic benefits but should not be considered the primary delivery method for follicle-specific effects
Peripheral neuropathy affects millions of people and is a growing concern, particularly amongst individuals living with diabetes and those who have long term nutritional absorption issues
Overall, both peptides appear to provide broad regenerative and repair potential, speeding up the healing of various tissues